Current Treatment Options for Acute Skin and Skin …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451992/
Apr 01, 2019 · Anti-MRSA agents for ABSSSIs include vancomycin, which is considered the first-line parenteral treatment of serious MRSA infections in hospitalized patients, as well as linezolid, daptomycin, and tigecycline (Table 3) . Other agents with reliable MRSA activity that have been approved for ABSSSIs include ceftaroline, tedizolid, dalbavancin, oritavancin, and …
DA: 41 PA: 90 MOZ Rank: 59